Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

616 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease.
Bueno de Mesquita M, Ferrante M, Henckaerts L, Joossens M, Janssens V, Hlavaty T, Pierik M, Joossens S, Van Schuerbeek N, Van Assche G, Rutgeerts P, Vermeire S, Hoffman I. Bueno de Mesquita M, et al. Among authors: hoffman i. Eur J Pediatr. 2009 May;168(5):575-83. doi: 10.1007/s00431-008-0798-7. Epub 2008 Aug 1. Eur J Pediatr. 2009. PMID: 18670786
Selection criteria and outcome of patients referred to intestinal transplantation: an European center experience.
Pirenne J, Hoffman I, Miserez M, Coosemans W, Aerts R, Monbaliu D, Ferdinande P, Hiele M, Van Assche G, Rutgeerts P, Janssens J, Tack J, Vlasselaers D, Desmet L, Nevens F, Veereman G, Fevery J, Lombaerts R. Pirenne J, et al. Among authors: hoffman i. Transplant Proc. 2006 Jul-Aug;38(6):1671-2. doi: 10.1016/j.transproceed.2006.05.063. Transplant Proc. 2006. PMID: 16908242
Predictors of early response to infliximab in patients with ulcerative colitis.
Ferrante M, Vermeire S, Katsanos KH, Noman M, Van Assche G, Schnitzler F, Arijs I, De Hertogh G, Hoffman I, Geboes JK, Rutgeerts P. Ferrante M, et al. Among authors: hoffman i. Inflamm Bowel Dis. 2007 Feb;13(2):123-8. doi: 10.1002/ibd.20054. Inflamm Bowel Dis. 2007. PMID: 17206703 Clinical Trial.
Infliximab for pediatric Crohn's disease.
Hoffman I, Vermeire S, Van Assche G, Rutgeerts P. Hoffman I, et al. Drugs Today (Barc). 2008 Aug;44(8):615-28. doi: 10.1358/dot.2008.44.8.1248345. Drugs Today (Barc). 2008. PMID: 18846272 Review.
Long-term outcome after infliximab for refractory ulcerative colitis.
Ferrante M, Vermeire S, Fidder H, Schnitzler F, Noman M, Van Assche G, De Hertogh G, Hoffman I, D'Hoore A, Van Steen K, Geboes K, Penninckx F, Rutgeerts P. Ferrante M, et al. Among authors: hoffman i. J Crohns Colitis. 2008 Sep;2(3):219-25. doi: 10.1016/j.crohns.2008.03.004. Epub 2008 May 16. J Crohns Colitis. 2008. PMID: 21172214
Levels of C-reactive protein are associated with response to infliximab therapy in patients with Crohn's disease.
Jürgens M, Mahachie John JM, Cleynen I, Schnitzler F, Fidder H, van Moerkercke W, Ballet V, Noman M, Hoffman I, van Assche G, Rutgeerts PJ, van Steen K, Vermeire S. Jürgens M, et al. Among authors: hoffman i. Clin Gastroenterol Hepatol. 2011 May;9(5):421-7.e1. doi: 10.1016/j.cgh.2011.02.008. Epub 2011 Feb 17. Clin Gastroenterol Hepatol. 2011. PMID: 21334460
616 results